MedPath

Positive Effects of Haematococcus Astaxanthin on Oxidative Stress and Lipid Profile in Overweight and Obese Adults

Not Applicable
Conditions
Healthy
Overweight
Obesity
Registration Number
NCT01167205
Lead Sponsor
Seoul National University Hospital
Brief Summary

The purpose of this study is to determine whether astaxanthin (ASX) supplementation will reduce obesity-induced oxidative stress and improve lipid profile in overweight and obese adults.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Subjects with BMI over 25.0 kg/m2
  • Non-smoker
Exclusion Criteria
  • Excessive alcohol consumption
  • Pregnant or lactating women
  • Dyslipidemia, hyperglycemia, or other chronic diseases.
  • Subjects who were taking vitamin supplements

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Evaluation of the plasma MDA (malonaldehyde) level12 weeks

MDA is a three chain aldehyde produced during the composition of a lipid hydroperoxide and is a well known indicator of lipid peroxidation.

The purpose of this stduy is to determine whether ASX supplementation lowers oxidative stress using MDA,a biomarker.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinical Research Institute Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath